# Stealth BioTherapeutics Inc. clinical trials: 25 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials with Stealth BioTherapeutics Inc. as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Stealth BioTherapeutics Inc.: 25 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/stealth-biotherapeutics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07927972 | Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Subcutaneous Injections of Elamipretide in Pediatric Subjects With Barth... | Stealth BioTherapeutics Inc. | Phase 1 | Not yet recruiting | Barth Syndrome | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927972) |
| April 15, 2026 | NCT07531251 | Clinical Trial in Patients With Barth Syndrome- 4TAZPower | Stealth BioTherapeutics Inc. | Phase 4 | Recruiting | Barth Syndrome | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07531251) |
| April 18, 2024 | NCT06373731 | ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related... | Stealth BioTherapeutics Inc. | Phase 3 | Active not recruiting | Age Related Macular Degeneration (ARMD) | 313 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06373731) |
| December 17, 2021 | NCT05162768 | Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) | Stealth BioTherapeutics Inc. | Phase 3 | Completed | Mitochondrial Myopathies, Mitochondrial Pathology, Mitochondrial DNA Mutation, Mitochondrial Diseases, Mitochondrial... | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05162768) |
| December 30, 2020 | NCT04689360 | An Intermediate Size Expanded Access Protocol of Elamipretide | Stealth BioTherapeutics Inc. | Not applicable | Available | Mitochondrial Diseases, Barth Syndrome | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04689360) |
| March 27, 2019 | NCT03891875 | ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Age-related Macular Degeneration | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03891875) |
| October 27, 2017 | NCT03323749 | A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension | Stealth BioTherapeutics Inc. | Phase 3 | Terminated | Primary Mitochondrial Myopathy | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03323749) |
| April 4, 2017 | NCT03098797 | A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome | Stealth BioTherapeutics Inc. | Phase 2/3 | Completed | Barth Syndrome | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03098797) |
| February 9, 2017 | NCT03048617 | An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300) | Stealth BioTherapeutics Inc. | Observational | Completed | Primary Mitochondrial Disease | 215 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03048617) |
| November 29, 2016 | NCT02976038 | Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed... | Stealth BioTherapeutics Inc. | Phase 2 | Terminated | Primary Mitochondrial Disease | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02976038) |
| September 26, 2016 | NCT02914665 | A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With... | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Heart Failure | 308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02914665) |
| July 28, 2016 | NCT02848313 | An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate... | Stealth BioTherapeutics Inc. | Phase 1 | Completed | Age-Related Macular Degeneration | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02848313) |
| June 27, 2016 | NCT02814097 | A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable... | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Chronic Heart Failure | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02814097) |
| June 20, 2016 | NCT02805790 | Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Primary Mitochondrial Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02805790) |
| June 2, 2016 | NCT02788747 | Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Heart Failure | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02788747) |
| February 26, 2016 | NCT02693119 | A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's... | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Leber's Hereditary Optic Neuropathy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02693119) |
| January 12, 2016 | NCT02653391 | A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs'... | Stealth BioTherapeutics Inc. | Phase 1/2 | Completed | Fuchs' Corneal Endothelial Dystrophy (FCED) | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02653391) |
| May 6, 2015 | NCT02436447 | A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired... | Stealth BioTherapeutics Inc. | Phase 1 | Completed | Normal and Impaired Renal Function | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02436447) |
| March 17, 2015 | NCT02388529 | A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With... | Stealth BioTherapeutics Inc. | Phase 1 | Withdrawn | Heart Failure | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02388529) |
| March 17, 2015 | NCT02388464 | A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure | Stealth BioTherapeutics Inc. | Phase 1 | Completed | Congestive Heart Failure | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02388464) |
| February 20, 2015 | NCT02367014 | Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy | Stealth BioTherapeutics Inc. | Phase 1/2 | Completed | Mitochondrial Myopathy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02367014) |
| December 11, 2014 | NCT02314299 | A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular... | Stealth BioTherapeutics Inc. | Phase 1/2 | Completed | Diabetic Macular Edema, Age-related Macular Degeneration | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02314299) |
| September 19, 2014 | NCT02245620 | A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Skeletal Muscle Mitochondrial Dysfunction in the Elderly | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02245620) |
| December 24, 2012 | NCT01755858 | Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery | Stealth BioTherapeutics Inc. | Phase 1/2 | Terminated | Renal Artery Obstruction, Hypertension, Renovascular, Ischemia Reperfusion Injury | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01755858) |
| April 6, 2012 | NCT01572909 | Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events | Stealth BioTherapeutics Inc. | Phase 2 | Completed | Reperfusion Injury, STEMI | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01572909) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 4 |
| Phase 2 | 9 |
| Phase 2/3 | 1 |
| Phase 3 | 3 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Terminated | 3 |
| Available | 1 |
| Recruiting | 1 |
| Active not recruiting | 1 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Heart Failure | 5 |
| Mitochondrial Myopathies | 4 |
| Barth Syndrome | 4 |
| Macular Degeneration | 4 |
| Reperfusion Injury | 2 |
| Mitochondrial Diseases | 2 |
| Muscular Diseases | 2 |
| ST Elevation Myocardial Infarction | 1 |
| Renal Artery Obstruction | 1 |
| Hypertension, Renovascular | 1 |
| Mitochondrial complex I deficiency | 1 |
| Muscle Weakness | 1 |
| Ophthalmoplegia, Chronic Progressive External | 1 |
| Optic Atrophy, Hereditary, Leber | 1 |
| Macular Edema | 1 |
| Fuchs' Endothelial Dystrophy | 1 |
| Renal Insufficiency | 1 |
| Myalgia | 1 |
| Edema | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Korean restaurants in the United States](https://specstream.ai/data/businesses/korean-restaurants/united-states)
- [Auto insurance agencies in the United States](https://specstream.ai/data/businesses/auto-insurance-agencies/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
- [Medical billing companies in the United States](https://specstream.ai/data/businesses/medical-billing-companies/united-states)
- [Bakeries in the United States](https://specstream.ai/data/businesses/bakeries/united-states)
